Global Cancer Technology
About this raise
Global Cancer Technology, with a post-money valuation of $11.6 million, is raising funds on NetCapital. It is an emerging medical technology company that may soon revolutionize cancer therapy. The technology of Global Cancer Technology is protected by several patents and is aimed at remote-controlled cancer drug delivery. Global Cancer Technology was founded by John P. Clark. The current round of crowdfunding has a minimum target of $10,000 and a maximum target of $107,000, and the proceeds will be used for pre-clinical work, research, marketing, commercialization, and general and administrative expenses. The technology of Global Cancer Technology was developed by scientists at Moores Cancer Center UC San Diego. Using the technology, the cancer drug will be attached to a nanocrystal scintillator and delivered to the body conveniently.
Investment Overview
Invested $107,000 :
Deal Terms
Company & Team
Company
- Year Founded
- 2017
- Industry
- Healthcare & Pharmaceuticals
- Tech Sector
- Location
- San Diego, California
- Company Website
-
Visit Website
Team
- Employees
- 1
Financials
Upgrade to gain access
-
$12.50 /month
billed annually - Free portfolio tracking, data-driven ratings, AI analysis and reports
- Plan Includes:
- Everything in Free, plus
- Company specific
Kingscrowd ratings and analyst reports
- Deal explorer and side-by-side comparison
- Startup exit and failure tracking
- Startup market filters and historical industry data
- Advanced company search ( with ratings)
- Get Edge Annual
Edge
Company Funding & Growth
Funding history
Close Date | Platform | Valuation | Total Raised | Security Type | Status | Reg Type |
---|---|---|---|---|---|---|
04/29/2022 | Netcapital | $26,682,636 | $0 | Equity - Common | Not Funded | RegCF |
09/08/2021 | Dalmore Group | - | $24,400 | Equity - Common | Funded | RegA+ |
02/25/2020 | Netcapital | $11,571,400 | $107,000 | Equity - Common | Funded | RegCF |
Growth Charts
Revenue History
Note: Revenue data points reflect the latest of either the most recent fiscal year's financials, or updated revenues directly from the founder, at each raise's close date.
Valuation History
Price per Share History
Note: Share prices shown in earlier rounds may not be indicative of any stock splits.